Torsten Haferlach

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 71

Top Topics

Acute Myeloid Leukemia

Peripheral Blood

Allogeneic Hematopoietic Stem Cell Transplantation

Top Venues

Blood cancer journal

Nature communications

Medizinische Genetik : Mitteilungsblatt des Berufsverbandes Medizinische Genetik e.V

This page only lists publications with an associated author ORCID identifier.

Publications

Sandra Huber, Natalie Wossidlo, Torsten Haferlach, Stephan Hutter, Wencke Walter, Christian Pohlkamp, Isolde Summerer, Henning Ruge, Constance Baer, Gregor Hoermann, Manja Meggendorfer, Wolfgang Kern, Claudia Haferlach
Parallel genomic analysis from paired bone marrow and peripheral blood samples of 200 cytopenic patients. Leukemia 38 (7) (2024)
Sandra Huber, Constance Baer, Stephan Hutter, Natalie Wossidlo, Gregor Hoermann, Christian Pohlkamp, Wencke Walter, Manja Meggendorfer, Wolfgang Kern, Torsten Haferlach, Claudia Haferlach
Genomic landscape of CCUS compared to MDS and its implications on risk prediction. Leukemia 38 (7) (2024)
Anna Sperk, Antje Gabriel, Daniela Koch, Abirami Augsburger, Victoria Sanchez, David Brockelt, Rupert Öllinger, Thomas Engleitner, Piero Giansanti, Romina Ludwig, Priska Auf der Maur, Wencke Walter, Torsten Haferlach, Irmela Jeremias, Roland Rad, Barbara Steigenberger, Bernhard Kuster, Ruth Eichner, Florian Bassermann
FBXL6 is a vulnerability in AML and unmasks proteolytic cleavage as a major experimental pitfall in myeloid cells. Leukemia 38 (9) (2024)
Yasuo Kubota, Xiaorong Gu, Laila Terkawi, Juraj Bodo, Bartlomiej P Przychodzen, Hussein Awada, Nakisha Williams, Carmelo Gurnari, Naomi Kawashima, Mai Aly, Arda Durmaz, Minako Mori, Ben Ponvilawan, Tariq Kewan, Waled Bahaj, Manja Meggendorfer, Babal Kant Jha, Valeria Visconte, Heesun Joyce Rogers, Torsten Haferlach, Jaroslaw P Maciejewski
Molecular and clinical analyses of PHF6 mutant myeloid neoplasia provide their pathogenesis and therapeutic targeting. Nature communications 15 (1) (2024)
Katharina Hörst, Constanze Kühn, Claudia Haferlach, Torsten Haferlach, Joseph D Khoury
Genetic studies in clonal haematopoiesis, myelodysplastic neoplasms and acute myeloid leukaemia - a practical guide to WHO-HAEM5. Medizinische Genetik : Mitteilungsblatt des Berufsverbandes Medizinische Genetik e.V 36 (1) (2024)
Philipp Ernst, Jenny Rinke, Georg-Nikolaus Franke, Frank Dicker, Torsten Haferlach, Thomas Ernst, Andreas Hochhaus
Treatment-free remission after third-line therapy with asciminib in chronic myeloid leukemia with an atypical e19a2 BCR::ABL1 transcript and T315I mutation. Leukemia 38 (9) (2024)
Sandra Huber, Constance Baer, Stephan Hutter, Natalie Wossidlo, Gregor Hoermann, Christian Pohlkamp, Wencke Walter, Manja Meggendorfer, Wolfgang Kern, Torsten Haferlach, Claudia Haferlach
Genomic landscape of CCUS compared to MDS and its implications on risk prediction. Leukemia 38 (7) (2024)
Sandra Huber, Natalie Wossidlo, Torsten Haferlach, Stephan Hutter, Wencke Walter, Christian Pohlkamp, Isolde Summerer, Henning Ruge, Constance Baer, Gregor Hoermann, Manja Meggendorfer, Wolfgang Kern, Claudia Haferlach
Parallel genomic analysis from paired bone marrow and peripheral blood samples of 200 cytopenic patients. Leukemia 38 (7) (2024)
Sandra Huber, Constance Baer, Stephan Hutter, Natalie Wossidlo, Gregor Hoermann, Christian Pohlkamp, Wencke Walter, Manja Meggendorfer, Wolfgang Kern, Torsten Haferlach, Claudia Haferlach
Genomic landscape of CCUS compared to MDS and its implications on risk prediction. Leukemia 38 (7) (2024)
Alberto Hernandez-Sanchez, Teresa González, Marta Sobas, Eric Sträng, Gastone C Castellani, María Abáigar, Peter J M Valk, Ángela Villaverde Ramiro, Axel Benner, Klaus H Metzeler, Raúl Azibeiro, Jesse Marc Tettero, Joaquin Martinez Lopez, Marta Pratcorona, Javier Martínez Elicegui, Kenneth Ian Mills, Christian Thiede, Guillermo F Sanz, Konstanze Döhner, Michael Heuser, Torsten Haferlach, Amin T Turki, Dirk Reinhardt, Renate Schulze-Rath, Martje Barbus, Jesús María Hernández-Rivas, Brian James Patrick Huntly, Gert Ossenkoppele, Hartmut Döhner, Lars Bullinger
Rearrangements involving 11q23.3/KMT2A in adult AML: mutational landscape and prognostic implications - a HARMONY study. Leukemia 38 (9) (2024)
Sandra Huber, Constance Baer, Stephan Hutter, Natalie Wossidlo, Gregor Hoermann, Christian Pohlkamp, Wencke Walter, Manja Meggendorfer, Wolfgang Kern, Torsten Haferlach, Claudia Haferlach
Genomic landscape of CCUS compared to MDS and its implications on risk prediction. Leukemia 38 (7) (2024)
Anna Sperk, Antje Gabriel, Daniela Koch, Abirami Augsburger, Victoria Sanchez, David Brockelt, Rupert Öllinger, Thomas Engleitner, Piero Giansanti, Romina Ludwig, Priska Auf der Maur, Wencke Walter, Torsten Haferlach, Irmela Jeremias, Roland Rad, Barbara Steigenberger, Bernhard Kuster, Ruth Eichner, Florian Bassermann
FBXL6 is a vulnerability in AML and unmasks proteolytic cleavage as a major experimental pitfall in myeloid cells. Leukemia 38 (9) (2024)
Sandra Huber, Natalie Wossidlo, Torsten Haferlach, Stephan Hutter, Wencke Walter, Christian Pohlkamp, Isolde Summerer, Henning Ruge, Constance Baer, Gregor Hoermann, Manja Meggendorfer, Wolfgang Kern, Claudia Haferlach
Parallel genomic analysis from paired bone marrow and peripheral blood samples of 200 cytopenic patients. Leukemia 38 (7) (2024)
Sandra Huber, Constance Baer, Stephan Hutter, Natalie Wossidlo, Gregor Hoermann, Christian Pohlkamp, Wencke Walter, Manja Meggendorfer, Wolfgang Kern, Torsten Haferlach, Claudia Haferlach
Genomic landscape of CCUS compared to MDS and its implications on risk prediction. Leukemia (2024)
Philipp Ernst, Jenny Rinke, Georg-Nikolaus Franke, Frank Dicker, Torsten Haferlach, Thomas Ernst, Andreas Hochhaus
Treatment-free remission after third-line therapy with asciminib in chronic myeloid leukemia with an atypical e19a2 BCR::ABL1 transcript and T315I mutation. Leukemia (2024)
Yasuo Kubota, Xiaorong Gu, Laila Terkawi, Juraj Bodo, Bartlomiej P Przychodzen, Hussein Awada, Nakisha Williams, Carmelo Gurnari, Naomi Kawashima, Mai Aly, Arda Durmaz, Minako Mori, Ben Ponvilawan, Tariq Kewan, Waled Bahaj, Manja Meggendorfer, Babal Kant Jha, Valeria Visconte, Heesun Joyce Rogers, Torsten Haferlach, Jaroslaw P Maciejewski
Molecular and clinical analyses of PHF6 mutant myeloid neoplasia provide their pathogenesis and therapeutic targeting. Nature communications 15 (1) (2024)
Philipp Ernst, Jenny Rinke, Georg-Nikolaus Franke, Frank Dicker, Torsten Haferlach, Thomas Ernst, Andreas Hochhaus
Treatment-free remission after third-line therapy with asciminib in chronic myeloid leukemia with an atypical e19a2 BCR::ABL1 transcript and T315I mutation. Leukemia 38 (9) (2024)
Sandra Huber, Natalie Wossidlo, Torsten Haferlach, Stephan Hutter, Wencke Walter, Christian Pohlkamp, Isolde Summerer, Henning Ruge, Constance Baer, Gregor Hoermann, Manja Meggendorfer, Wolfgang Kern, Claudia Haferlach
Parallel genomic analysis from paired bone marrow and peripheral blood samples of 200 cytopenic patients. Leukemia (2024)
Philipp Ernst, Jenny Rinke, Georg-Nikolaus Franke, Frank Dicker, Torsten Haferlach, Thomas Ernst, Andreas Hochhaus
Treatment-free remission after third-line therapy with asciminib in chronic myeloid leukemia with an atypical e19a2 BCR::ABL1 transcript and T315I mutation. Leukemia 38 (9) (2024)
Sandra Huber, Natalie Wossidlo, Torsten Haferlach, Stephan Hutter, Wencke Walter, Christian Pohlkamp, Isolde Summerer, Henning Ruge, Constance Baer, Gregor Hoermann, Manja Meggendorfer, Wolfgang Kern, Claudia Haferlach
Parallel genomic analysis from paired bone marrow and peripheral blood samples of 200 cytopenic patients. Leukemia 38 (7) (2024)
Yasuo Kubota, Xiaorong Gu, Laila Terkawi, Juraj Bodo, Bartlomiej P Przychodzen, Hussein Awada, Nakisha Williams, Carmelo Gurnari, Naomi Kawashima, Mai Aly, Arda Durmaz, Minako Mori, Ben Ponvilawan, Tariq Kewan, Waled Bahaj, Manja Meggendorfer, Babal Kant Jha, Valeria Visconte, Heesun Joyce Rogers, Torsten Haferlach, Jaroslaw P Maciejewski
Molecular and clinical analyses of PHF6 mutant myeloid neoplasia provide their pathogenesis and therapeutic targeting. Nature communications 15 (1) (2024)
Anna Sperk, Antje Gabriel, Daniela Koch, Abirami Augsburger, Victoria Sanchez, David Brockelt, Rupert Öllinger, Thomas Engleitner, Piero Giansanti, Romina Ludwig, Priska Auf der Maur, Wencke Walter, Torsten Haferlach, Irmela Jeremias, Roland Rad, Barbara Steigenberger, Bernhard Kuster, Ruth Eichner, Florian Bassermann
FBXL6 is a vulnerability in AML and unmasks proteolytic cleavage as a major experimental pitfall in myeloid cells. Leukemia 38 (9) (2024)
Alberto Hernandez-Sanchez, Teresa González, Marta Sobas, Eric Sträng, Gastone C Castellani, María Abáigar, Peter J M Valk, Ángela Villaverde Ramiro, Axel Benner, Klaus H Metzeler, Raúl Azibeiro, Jesse Marc Tettero, Joaquin Martinez Lopez, Marta Pratcorona, Javier Martínez Elicegui, Kenneth Ian Mills, Christian Thiede, Guillermo F Sanz, Konstanze Döhner, Michael Heuser, Torsten Haferlach, Amin T Turki, Dirk Reinhardt, Renate Schulze-Rath, Martje Barbus, Jesús María Hernández-Rivas, Brian James Patrick Huntly, Gert Ossenkoppele, Hartmut Döhner, Lars Bullinger
Rearrangements involving 11q23.3/KMT2A in adult AML: mutational landscape and prognostic implications - a HARMONY study. Leukemia 38 (9) (2024)
Yasuo Kubota, Xiaorong Gu, Laila Terkawi, Juraj Bodo, Bartlomiej P Przychodzen, Hussein Awada, Nakisha Williams, Carmelo Gurnari, Naomi Kawashima, Mai Aly, Arda Durmaz, Minako Mori, Ben Ponvilawan, Tariq Kewan, Waled Bahaj, Manja Meggendorfer, Babal Kant Jha, Valeria Visconte, Heesun Joyce Rogers, Torsten Haferlach, Jaroslaw P Maciejewski
Molecular and clinical analyses of PHF6 mutant myeloid neoplasia provide their pathogenesis and therapeutic targeting. Nature communications 15 (1) (2024)
Anna Sperk, Antje Gabriel, Daniela Koch, Abirami Augsburger, Victoria Sanchez, David Brockelt, Rupert Öllinger, Thomas Engleitner, Piero Giansanti, Romina Ludwig, Priska Auf der Maur, Wencke Walter, Torsten Haferlach, Irmela Jeremias, Roland Rad, Barbara Steigenberger, Bernhard Kuster, Ruth Eichner, Florian Bassermann
FBXL6 is a vulnerability in AML and unmasks proteolytic cleavage as a major experimental pitfall in myeloid cells. Leukemia (2024)
Tariq Kewan, Arda Durmaz, Waled Bahaj, Carmelo Gurnari, Laila Terkawi, Hussein Awada, Olisaemeka D Ogbue, Ramsha Ahmed, Simona Pagliuca, Hassan Awada, Yasuo Kubota, Minako Mori, Ben Ponvilawan, Bayan Al-Share, Bhumika J Patel, Hetty E Carraway, Jacob Scott, Suresh K Balasubramanian, Taha Bat, Yazan F Madanat, Mikkael A Sekeres, Torsten Haferlach, Valeria Visconte, Jaroslaw P Maciejewski
Author Correction: Molecular patterns identify distinct subclasses of myeloid neoplasia. Nature communications 15 (1) (2024)
Claudia Haferlach, German Ott, Katharina Hörst, Constanze Kühn, Torsten Haferlach, Reiner Siebert
Overview on WHO-HAEM5 and the diagnostic relevance of genetic alterations for the classification. Medizinische Genetik : Mitteilungsblatt des Berufsverbandes Medizinische Genetik e.V 36 (1) (2024)
Alberto Hernandez-Sanchez, Teresa González, Marta Sobas, Eric Sträng, Gastone C Castellani, María Abáigar, Peter J M Valk, Ángela Villaverde Ramiro, Axel Benner, Klaus H Metzeler, Raúl Azibeiro, Jesse Marc Tettero, Joaquin Martinez Lopez, Marta Pratcorona, Javier Martínez Elicegui, Kenneth Ian Mills, Christian Thiede, Guillermo F Sanz, Konstanze Döhner, Michael Heuser, Torsten Haferlach, Amin T Turki, Dirk Reinhardt, Renate Schulze-Rath, Martje Barbus, Jesús María Hernández-Rivas, Brian James Patrick Huntly, Gert Ossenkoppele, Hartmut Döhner, Lars Bullinger
Rearrangements involving 11q23.3/KMT2A in adult AML: mutational landscape and prognostic implications - a HARMONY study. Leukemia (2024)
Katharina Hörst, Constanze Kühn, Claudia Haferlach, Torsten Haferlach, Joseph D Khoury
Genetic studies in clonal haematopoiesis, myelodysplastic neoplasms and acute myeloid leukaemia - a practical guide to WHO-HAEM5. Medizinische Genetik : Mitteilungsblatt des Berufsverbandes Medizinische Genetik e.V 36 (1) (2024)
Claudia Haferlach, German Ott, Katharina Hörst, Constanze Kühn, Torsten Haferlach, Reiner Siebert
Overview on WHO-HAEM5 and the diagnostic relevance of genetic alterations for the classification. Medizinische Genetik : Mitteilungsblatt des Berufsverbandes Medizinische Genetik e.V 36 (1) (2024)
Alberto Hernandez-Sanchez, Teresa González, Marta Sobas, Eric Sträng, Gastone C Castellani, María Abáigar, Peter J M Valk, Ángela Villaverde Ramiro, Axel Benner, Klaus H Metzeler, Raúl Azibeiro, Jesse Marc Tettero, Joaquin Martinez Lopez, Marta Pratcorona, Javier Martínez Elicegui, Kenneth Ian Mills, Christian Thiede, Guillermo F Sanz, Konstanze Döhner, Michael Heuser, Torsten Haferlach, Amin T Turki, Dirk Reinhardt, Renate Schulze-Rath, Martje Barbus, Jesús María Hernández-Rivas, Brian James Patrick Huntly, Gert Ossenkoppele, Hartmut Döhner, Lars Bullinger
Rearrangements involving 11q23.3/KMT2A in adult AML: mutational landscape and prognostic implications - a HARMONY study. Leukemia 38 (9) (2024)
Tariq Kewan, Arda Durmaz, Waled Bahaj, Carmelo Gurnari, Laila Terkawi, Hussein Awada, Olisaemeka D Ogbue, Ramsha Ahmed, Simona Pagliuca, Hassan Awada, Yasuo Kubota, Minako Mori, Ben Ponvilawan, Bayan Al-Share, Bhumika J Patel, Hetty E Carraway, Jacob Scott, Suresh K Balasubramanian, Taha Bat, Yazan F Madanat, Mikkael A Sekeres, Torsten Haferlach, Valeria Visconte, Jaroslaw P Maciejewski
Author Correction: Molecular patterns identify distinct subclasses of myeloid neoplasia. Nature communications 15 (1) (2024)
Torsten Haferlach, Wencke Walter
Challenging gold standard hematology diagnostics through the introduction of whole genome sequencing and artificial intelligence. International journal of laboratory hematology (2023)
Torsten Haferlach, Wencke Walter
Challenging gold standard hematology diagnostics through the introduction of whole genome sequencing and artificial intelligence. International journal of laboratory hematology 45 (2) (2023)
Holly Lee, Sungwoo Ahn, Ranjan Maity, Noemie Leblay, Bachisio Ziccheddu, Marietta Truger, Monika Chojnacka, Anthony Cirrincione, Michael A Durante, Remi Tilmont, Elie Barakat, Mansour Poorebrahim, Sarthak Sinha, John McIntyre, Angela M Y Chan, Holly Wilson, Shari Kyman, Amrita Krishnan, Carl Ola Landgren, Wencke Walter, Manja Meggendorfer, Claudia Haferlach, Torsten Haferlach, Hermann Einsele, Klaus Martin Kortüm, Stefan Knop, Jean Baptiste Alberge, Andreas Rosenwald, Jonathan J Keats, Leo Rasche, Francesco Maura, Paola Neri, Nizar J Bahlis
Mechanisms of antigen escape from BCMA- or GPRC5D-targeted immunotherapies in multiple myeloma. Nature medicine (2023)
Elizabeth Heyes, Anna S Wilhelmson, Anne Wenzel, Gabriele Manhart, Thomas Eder, Mikkel B Schuster, Edwin Rzepa, Sachin Pundhir, Teresa D'Altri, Anne-Katrine Frank, Coline Gentil, Jakob Woessmann, Erwin M Schoof, Manja Meggendorfer, Juerg Schwaller, Torsten Haferlach, Florian Grebien, Bo Torben Porse
TET2 lesions enhance the aggressiveness of CEBPA-mutant acute myeloid leukemia by rebalancing GATA2 expression. Nature communications 14 (1) (2023)
Sandra Huber, Torsten Haferlach, Heiko Müller, Manja Meggendorfer, Stephan Hutter, Gregor Hoermann, Constance Baer, Wolfgang Kern, Claudia Haferlach
MDS subclassification-do we still have to count blasts? Leukemia (2023)
José Guilherme de Almeida, Emma Gudgin, Martin Besser, William G Dunn, Jonathan Cooper, Torsten Haferlach, George S Vassiliou, Moritz Gerstung
Computational analysis of peripheral blood smears detects disease-associated cytomorphologies. Nature communications 14 (1) (2023)
Bing Z Carter, Po Yee Mak, Wenjing Tao, Edward Ayoub, Lauren B Ostermann, Xuelin Huang, Sanam Loghavi, Steffen Boettcher, Yuki Nishida, Vivian Ruvolo, Paul E Hughes, Phuong K Morrow, Torsten Haferlach, Steven Mitchell Kornblau, Muharrem Muftuoglu, Michael Andreeff
Combined inhibition of BCL-2 and MCL-1 overcomes BAX deficiency-mediated resistance of TP53-mutant acute myeloid leukemia to individual BH3 mimetics. Blood cancer journal 13 (1) (2023)
Bing Z Carter, Po Yee Mak, Wenjing Tao, Edward Ayoub, Lauren B Ostermann, Xuelin Huang, Sanam Loghavi, Steffen Boettcher, Yuki Nishida, Vivian Ruvolo, Paul E Hughes, Phuong K Morrow, Torsten Haferlach, Steven Mitchell Kornblau, Muharrem Muftuoglu, Michael Andreeff
Correction: Combined inhibition of BCL-2 and MCL-1 overcomes BAX deficiency-mediated resistance of TP53-mutant acute myeloid leukemia to individual BH3 mimetics. Blood cancer journal 13 (1) (2023)
Torsten Haferlach, Wencke Walter
Challenging gold standard hematology diagnostics through the introduction of whole genome sequencing and artificial intelligence. International journal of laboratory hematology 45 (2) (2023)
Sandra Huber, Constance Baer, Stephan Hutter, Frank Dicker, Irene Fuhrmann, Manja Meggendorfer, Christian Pohlkamp, Wolfgang Kern, Torsten Haferlach, Claudia Haferlach, Gregor Hoermann
Risk assessment according to IPSS-M is superior to AML ELN risk classification in MDS/AML overlap patients defined by ICC. Leukemia (2023)
Torsten Haferlach, Wencke Walter
Challenging gold standard hematology diagnostics through the introduction of whole genome sequencing and artificial intelligence. International journal of laboratory hematology 45 (2) (2023)
Sandra Huber, Constance Baer, Stephan Hutter, Frank Dicker, Manja Meggendorfer, Christian Pohlkamp, Wolfgang Kern, Torsten Haferlach, Claudia Haferlach, Gregor Hoermann
AML classification in the year 2023: How to avoid a Babylonian confusion of languages. Leukemia (2023)
Bing Z Carter, Po Yee Mak, Wenjing Tao, Edward Ayoub, Lauren B Ostermann, Xuelin Huang, Sanam Loghavi, Steffen Boettcher, Yuki Nishida, Vivian Ruvolo, Paul E Hughes, Phuong K Morrow, Torsten Haferlach, Steven Mitchell Kornblau, Muharrem Muftuoglu, Michael Andreeff
Combined inhibition of BCL-2 and MCL-1 overcomes BAX deficiency-mediated resistance of TP53-mutant acute myeloid leukemia to individual BH3 mimetics. Blood cancer journal 13 (1) (2023)
Maki Sakuma, Piers Blombery, Manja Meggendorfer, Claudia Haferlach, Markus Lindauer, Uwe M Martens, Wolfgang Kern, Torsten Haferlach, Wencke Walter
Novel causative variants of VEXAS in UBA1 detected through whole genome transcriptome sequencing in a large cohort of hematological malignancies. Leukemia (2023)
Bing Z Carter, Po Yee Mak, Wenjing Tao, Edward Ayoub, Lauren B Ostermann, Xuelin Huang, Sanam Loghavi, Steffen Boettcher, Yuki Nishida, Vivian Ruvolo, Paul E Hughes, Phuong K Morrow, Torsten Haferlach, Steven Mitchell Kornblau, Muharrem Muftuoglu, Michael Andreeff
Combined inhibition of BCL-2 and MCL-1 overcomes BAX deficiency-mediated resistance of TP53-mutant acute myeloid leukemia to individual BH3 mimetics. Blood cancer journal 13 (1) (2023)
Bing Z Carter, Po Yee Mak, Wenjing Tao, Edward Ayoub, Lauren B Ostermann, Xuelin Huang, Sanam Loghavi, Steffen Boettcher, Yuki Nishida, Vivian Ruvolo, Paul E Hughes, Phuong K Morrow, Torsten Haferlach, Steven Mitchell Kornblau, Muharrem Muftuoglu, Michael Andreeff
Combined inhibition of BCL-2 and MCL-1 overcomes BAX deficiency-mediated resistance of TP53-mutant acute myeloid leukemia to individual BH3 mimetics. Blood cancer journal 13 (1) (2023)
Bing Z Carter, Po Yee Mak, Wenjing Tao, Edward Ayoub, Lauren B Ostermann, Xuelin Huang, Sanam Loghavi, Steffen Boettcher, Yuki Nishida, Vivian Ruvolo, Paul E Hughes, Phuong K Morrow, Torsten Haferlach, Steven Mitchell Kornblau, Muharrem Muftuoglu, Michael Andreeff
Combined inhibition of BCL-2 and MCL-1 overcomes BAX deficiency-mediated resistance of TP53-mutant acute myeloid leukemia to individual BH3 mimetics. Blood cancer journal 13 (1) (2023)
Bing Z Carter, Po Yee Mak, Wenjing Tao, Edward Ayoub, Lauren B Ostermann, Xuelin Huang, Sanam Loghavi, Steffen Boettcher, Yuki Nishida, Vivian Ruvolo, Paul E Hughes, Phuong K Morrow, Torsten Haferlach, Steven Mitchell Kornblau, Muharrem Muftuoglu, Michael Andreeff
Combined inhibition of BCL-2 and MCL-1 overcomes BAX deficiency-mediated resistance of TP53-mutant acute myeloid leukemia to individual BH3 mimetics. Blood cancer journal 13 (1) (2023)
Bing Z Carter, Po Yee Mak, Wenjing Tao, Edward Ayoub, Lauren B Ostermann, Xuelin Huang, Sanam Loghavi, Steffen Boettcher, Yuki Nishida, Vivian Ruvolo, Paul E Hughes, Phuong K Morrow, Torsten Haferlach, Steven Mitchell Kornblau, Muharrem Muftuoglu, Michael Andreeff
Correction: Combined inhibition of BCL-2 and MCL-1 overcomes BAX deficiency-mediated resistance of TP53-mutant acute myeloid leukemia to individual BH3 mimetics. Blood cancer journal 13 (1) (2023)
Bing Z Carter, Po Yee Mak, Wenjing Tao, Edward Ayoub, Lauren B Ostermann, Xuelin Huang, Sanam Loghavi, Steffen Boettcher, Yuki Nishida, Vivian Ruvolo, Paul E Hughes, Phuong K Morrow, Torsten Haferlach, Steven Mitchell Kornblau, Muharrem Muftuoglu, Michael Andreeff
Combined inhibition of BCL-2 and MCL-1 overcomes BAX deficiency-mediated resistance of TP53-mutant acute myeloid leukemia to individual BH3 mimetics. Blood cancer journal 13 (1) (2023)
Minako Mori, Yasuo Kubota, Arda Durmaz, Carmelo Gurnari, Charnise Goodings, Vera Adema, Ben Ponvilawan, Waled S Bahaj, Tariq Kewan, Thomas LaFramboise, Manja Meggendorfer, Claudia Haferlach, John Barnard, Marcin Wlodarski, Valeria Visconte, Torsten Haferlach, Jaroslaw P Maciejewski
Genomics of deletion 7 and 7q in myeloid neoplasm: from pathogenic culprits to potential synthetic lethal therapeutic targets. Leukemia (2023)
Tariq Kewan, Arda Durmaz, Waled Bahaj, Carmelo Gurnari, Laila Terkawi, Hussein Awada, Olisaemeka D Ogbue, Ramsha Ahmed, Simona Pagliuca, Hassan Awada, Yasuo Kutoba, Minako Mori, Ben Ponvilawan, Bayan Al-Share, Bhumika J Patel, Hetty E Carraway, Jacob Scott, Suresh K Balasubramanian, Taha Bat, Yazan F Madanat, Mikkael A Sekeres, Torsten Haferlach, Valeria Visconte, Jaroslaw P Maciejewski
Molecular patterns identify distinct subclasses of myeloid neoplasia. Nature communications 14 (1) (2023)
Bing Z Carter, Po Yee Mak, Wenjing Tao, Edward Ayoub, Lauren B Ostermann, Xuelin Huang, Sanam Loghavi, Steffen Boettcher, Yuki Nishida, Vivian Ruvolo, Paul E Hughes, Phuong K Morrow, Torsten Haferlach, Steven Mitchell Kornblau, Muharrem Muftuoglu, Michael Andreeff
Combined inhibition of BCL-2 and MCL-1 overcomes BAX deficiency-mediated resistance of TP53-mutant acute myeloid leukemia to individual BH3 mimetics. Blood cancer journal 13 (1) (2023)
Sandra Huber, Torsten Haferlach, Manja Meggendorfer, Stephan Hutter, Gregor Hoermann, Isolde Summerer, Irene Fuhrmann, Constance Baer, Wolfgang Kern, Claudia Haferlach
Mutations in spliceosome genes in myelodysplastic neoplasms and their association to ring sideroblasts. Leukemia (2022)
Simona Pagliuca, Carmelo Gurnari, Colin Hercus, Sebastien Hergalant, Niroshan Nadarajah, Adam Wahida, Laila Terkawi, Minako Mori, Weiyin Zhou, Valeria Visconte, Stephen R Spellman, Shahinaz M Gadalla, Caiying Zhu, Caiying Zhu, Torsten Haferlach, Jaroslaw P Maciejewski
Molecular landscape of immune pressure and escape in aplastic anemia. Leukemia (2022)
Heiko Müller, Wencke Walter, Stephan Hutter, Niroshan Nadarajah, Manja Meggendorfer, Wolfgang Kern, Torsten Haferlach, Claudia Haferlach
Aberrant somatic hypermutation of CCND1 generates non-coding drivers of mantle cell lymphomagenesis. Cancer gene therapy 29 (5) (2022)
Birgit Burkhardt, Ulf Michgehl, Jonas Rohde, Tabea Erdmann, Philipp Berning, Katrin Reutter, Marius Rohde, Arndt Borkhardt, Thomas Burmeister, Sandeep S Dave, Alexandar Tzankov, Martin Dugas, Sarah Sandmann, Falko Fend, Jasmin Finger, Stephanie Mueller, Nicola Gökbuget, Torsten Haferlach, Wolfgang Kern, Wolfgang Hartmann, Wolfram Klapper, Ilske Oschlies, Julia Richter, Anna Makowska, Mathias Lutz, Brtitta Maecker-Kolhoff, German Ott, Andreas Rosenwald, Reiner Siebert, Arend V Stackelberg, Brigitte Strahm, Wilhelm Woessmann, Martin Zimmermann, Myroslav Zapukhlyak, Michael Grau, Georg Lenz
Clinical relevance of molecular characteristics in Burkitt lymphoma differs according to age. Nature communications 13 (1) (2022)
Constance Baer, Shunsuke Kimura, Mitra Shumsher Rana, Andrew B Kleist, Tim Flerlage, Thomas P Loughran, Peter J Chockley, Wencke Walter, Manja Meggendorfer, Thomas L Olson, HeeJin Cheon, Kristine C Olson, Aakrosh Ratan, Martha-Lena Mueller, James M Foran, Laura J Janke, Chunxu Qu, Shaina N Porter, Shondra M Pruett-Miller, Ravi C Kalathur, Claudia Haferlach, Wolfgang Kern, Elisabeth Paietta, Paul Glyndwr Thomas, M Madan Babu, Thomas P Loughran, Ilaria Iacobucci, Torsten Haferlach, Charles G Mullighan
CCL22 mutations drive natural killer cell lymphoproliferative disease by deregulating microenvironmental crosstalk. Nature genetics 54 (5) (2022)
Sandra Huber, Torsten Haferlach, Manja Meggendorfer, Stephan Hutter, Gregor Hoermann, Constance Baer, Wolfgang Kern, Claudia Haferlach
SF3B1 mutations in AML are strongly associated with MECOM rearrangements and may be indicative of an MDS pre-phase. Leukemia 36 (12) (2022)
Sandra Huber, Torsten Haferlach, Manja Meggendorfer, Stephan Hutter, Gregor Hoermann, Constance Baer, Wolfgang Kern, Claudia Haferlach
SF3B1 mutated MDS: Blast count, genetic co-abnormalities and their impact on classification and prognosis. Leukemia 36 (12) (2022)
Peter Valent, Amy D Klion, Florence Roufosse, Dagmar Simon, Georgia Metzgeroth, Kristin M Leiferman, Juliana Schwaab, Joseph H Butterfield, Wolfgang R Sperr, Karl Sotlar, Peter Vandenberghe, Gregor Hoermann, Torsten Haferlach, Richard Moriggl, Tracy I George, Cem Akin, Bruce S Bochner, Jason Gotlib, Andreas Reiter, Hans-Peter Horny, Michel Arock, Hans-Uwe Simon, Gerald J Gleich
Proposed refined diagnostic criteria and classification of eosinophil disorders and related syndromes. Allergy (2022)
Janine Müller, Wencke Walter, Claudia Haferlach, Heiko Müller, Irene Fuhrmann, Martha-Lena Müller, Henning Ruge, Manja Meggendorfer, Wolfgang Kern, Torsten Haferlach, Anna Stengel
Correction: How T-lymphoblastic leukemia can be classified based on genetics using standard diagnostic techniques enhanced by whole genome sequencing. Leukemia (2022)
Janine Müller, Wencke Walter, Claudia Haferlach, Heiko Müller, Irene Fuhrmann, Martha-Lena Müller, Henning Ruge, Manja Meggendorfer, Wolfgang Kern, Torsten Haferlach, Anna Stengel
Correction: How T-lymphoblastic leukemia can be classified based on genetics using standard diagnostic techniques enhanced by whole genome sequencing. Leukemia (2022)
Sunisa Kongkiatkamon, Laila Terkawi, Yihong Guan, Vera Adema, Metis Hasipek, Tatiana Dombrovski, Milo Co, Wencke Walter, Hassan Awada, Yvonne Parker, Stephan Hutter, Simona Pagliuca, Carmelo Gurnari, Heesun Joyce Rogers, Manja Meggendorfer, Daniel J Lindner, Torsten Haferlach, Valeria Visconte, Thomas LaFramboise, Babal Kant Jha, Jaroslaw P Maciejewski
Rare germline alterations of myeloperoxidase predispose to myeloid neoplasms. Leukemia 36 (8) (2022)
Joseph D Khoury, Eric Solary, Oussama Abla, Yassmine M N Akkari, Rita Alaggio, Jane F Apperley, Rafael Bejar, Emilio Berti, Lambert Busque, John K C Chan, Weina Chen, Xueyan Chen, Wee-Joo Chng, John Kim Choi, Isabel Colmenero, Sarah E Coupland, Nicholas C P Cross, Daphne De Jong, M Tarek Elghetany, Emiko Takahashi, Jean François Emile, Judith Ferry, Linda Fogelstrand, Michaela Fontenay, Ulrich Germing, Sumeet Gujral, Torsten Haferlach, Claire Harrison, Jennelle C Hodge, Shimin Hu, Joop H Jansen, Rashmi Kanagal-Shamana, Hagop M Kantarjian, Christian Peter Kratz, Xiao-Qiu Li, Megan S Lim, Keith Loeb, Sanam Loghavi, Andrea Marcogliese, Soheil Meshinchi, Phillip Michaels, Kikkeri N Naresh, Yasodha Natkunam, Reza Nejati, German Ott, Eric Padron, Keyur P Patel, Nikhil V Patkar, Jennifer Picarsic, Uwe Platzbecker, Irene Roberts, Anna Schuh, William Sewell, Reiner Siebert, Prashant Ramesh Tembhare, Jeffrey W Tyner, Srdan Verstovsek, Wei Wang, Brent Wood, Wenbin Xiao, Cecilia C S Yeung, Andreas Hochhaus
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms. Leukemia 36 (7) (2022)
Borwyn A Wang, Hrishikesh M Mehta, Srinivasa R Penumutchu, Blanton S Tolbert, Chonghui Cheng, Marek Kimmel, Torsten Haferlach, Jaroslaw P Maciejewski, Seth J Corey
Alternatively spliced CSF3R isoforms in SRSF2 P95H mutated myeloid neoplasms. Leukemia 36 (10) (2022)
Irene Fuhrmann, Miriam Lenk, Torsten Haferlach, Anna Stengel, Stephan Hutter, Constance Baer, Manja Meggendorfer, Wolfgang Kern, Claudia Haferlach
AML, NOS and AML-MRC as defined by multilineage dysplasia share a common mutation pattern which is distinct from AML-MRC as defined by MDS-related cytogenetics. Leukemia 36 (7) (2022)
Janine Müller, Wencke Walter, Claudia Haferlach, Heiko Müller, Irene Fuhrmann, Martha-Lena Müller, Henning Ruge, Manja Meggendorfer, Wolfgang Kern, Torsten Haferlach, Anna Stengel
How T-lymphoblastic leukemia can be classified based on genetics using standard diagnostic techniques enhanced by whole genome sequencing. Leukemia (2022)
Wencke Walter, Claudia Haferlach, Niroshan Nadarajah, Ines Schmidts, Constanze Kühn, Wolfgang Kern, Torsten Haferlach
How artificial intelligence might disrupt diagnostics in hematology in the near future. Oncogene 40 (25) (2021)